Moelis & Company
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MC research report →
Range $60 – $85
Price Chart
About the company
Moelis & Company operates as a dedicated investment banking advisory firm, offering expert counsel on a wide range of corporate finance matters. Its core services include strategic guidance for mergers and acquisitions (M&A), corporate recapitalizations and restructurings, and capital market transactions. The firm serves a diverse global client base, which encompasses large public multinational corporations, private middle-market businesses, financial sponsors, entrepreneurs, governmental organizations, and sovereign wealth funds.
- CEO
- Navid Mahmoodzadegan
- IPO
- 2014
- Employees
- 1,416
- HQ
- New York City, NY, US
AI snapshot
Six angles, distilled from the data.
The stock is in a constructive multi-month uptrend, trading above both the 50-day and 200-day moving averages. It sits in the upper half of its 52-week range, though still below the peak, which points to a firm but not stretched regime.
Street sentiment is mixed but still centered on Hold, with 6 Buys, 12 Holds, and 4 Sells. The consensus target sits at 72.5, modestly above the current level, while recent revisions split between Morgan Stanley lifting its target to $85 and UBS cutting to $60 and downgrading to Sell.
Moelis has a strong beat profile, with 7 of the last 8 quarters topping EPS estimates. Next-year EPS is modeled at 3.9166 versus 2.87 TTM, so shareholders should watch whether advisory activity keeps translating into earnings leverage after the latest 0.63 versus 0.62 beat.
Recent insider activity leans negative on a discretionary basis, with one officer sale of 4,850 shares for $336,105. The rest of the activity is award-related director grants, which are routine compensation flows rather than a trading signal.
Profitability is strong, led by a 92.3% gross margin and a 14.5% net margin. Revenue grew 12% year over year and earnings rose 17.1%, while the balance sheet remains net cash positive at $241.44 million with $508.6 million of cash and equivalents.
Moelis screens as a premium capital markets franchise, with high returns on equity at 41.45% and return on assets at 18.65%. The valuation is not cheap versus the sector, but the setup is supported by durable margins and a cash-rich balance sheet.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.90B
- P/E
- 21.88
- Fwd P/E
- 21.25
- PEG
- 1.79
- P/S
- 3.12
- P/B
- 9.90
- EV/EBITDA
- 15.84
- Div Yield
- 3.93%
- Gross Margin
- 69.91%
- Op Margin
- 18.40%
- Net Margin
- 14.50%
- ROE
- 43.55%
- ROIC
- 26.05%
Latest fiscal year · YoY change
- Revenue
- $1.52B+27.0%
- Gross Profit
- $1.50B+313.0%
- Op Income
- $273.86M
- Net Income
- $233.04M+71.3%
- EPS
- $3.11+64.6%
- OCF Growth
- +34.8%
- FCF Growth
- +30.0%
- 52W High
- $78.22
- 52W Low
- $51.06
- 50D MA
- $67.20
- 200D MA
- $65.83
- Beta
- 1.84
- RSI (14)
- 48
- Avg Volume
- 933.32K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Moelis posted record second-quarter and first-half revenue as stronger M&A, capital markets, and private capital advisory activity drove growth and management said the back half looks strong.· July 29, 2026
- Record Q2 revenue of $409 million, up 12% year over year; first-half revenue of $729 million, up 9%.
- Adjusted compensation ratio improved to 65.8% from 69% a year ago, helping pretax margin rise to 18.6% from 17.6%.
- Capital markets and private capital advisory were key growth engines, while non-M&A businesses generated record first-half revenue.
- Announced pipeline was up more than 80% year over year at quarter-end, and management said new business origination accelerated in Q2.
- The firm ended with $481 million of cash and no debt, and continued share repurchases and dividends returned capital to shareholders.
Second-quarter revenue was $409 million, up 12% year over year, and first-half revenue was $729 million, up 9%. Adjusted compensation ratio was 65.8% in both the second quarter and first half, versus 69% in the prior-year periods. Adjusted non-compensation expenses were $66.5 million in Q2 and $134 million in the first half, with pretax margin of 18.6% in Q2 and 17% year to date, both above last year. Management did not give formal revenue or EPS guidance, but said the announced pipeline was up over 80% year over year, the overall pipeline was at a record level, and it expected a strong second half. CFO commentary pointed to quarterly non-comp expenses in the mid to high $60 million range for the rest of the year; the dividend stayed at $0.65 per share, Q2 buybacks totaled about 337 thousand shares at an average price of $64.43, and the quarter ended with $481 million of cash and no debt.
Navid Mahmoodzadegan said the quarter reflected improving M&A conditions, record activity in non-M&A businesses, and the benefits of recent investment in talent and product expansion. He emphasized that larger transactions are becoming a bigger part of the franchise, sponsor engagement remains high, and the firm is seeing early signs of a broader M&A recovery, including a possible pickup in the $1 billion to $5 billion range. His tone was confident and optimistic, repeatedly pointing to a record pipeline, a strong second half, and continued progress on AI adoption.
Christopher Callesano focused on margin improvement and expense discipline. He said the adjusted compensation ratio improved to 65.8% from 69% a year ago, adjusted non-comp expenses were $66.5 million in Q2, and pretax margin improved to 18.6% from 17.6%; for the first half, non-comp expenses were $134 million and pretax margin was 17% versus 16% last year. He attributed higher non-comp costs mainly to more business activity, underwriting syndication costs tied to public equity capital markets, and ongoing investment in technology, data, and occupancy, and he said quarterly non-comp expenses should stay in the mid to high $60 million range. He also highlighted capital returns: a $0.65 quarterly dividend, roughly 337 thousand shares repurchased in Q2 at $64.43, about $141 million returned through repurchases and settlements in the first half, and $481 million of cash with no debt.
Analysts pressed on whether the firm can sustain a second-half revenue step-up, the rise in senior talent costs, the softer sponsor M&A backdrop, and the impact of AI on margins and productivity. Management said it is not making specific second-half revenue predictions, but the record announced pipeline and stronger new business activity give it confidence. On sponsor engagement, Navid said engagement is very high; the issue is that many sponsor-owned companies still have not grown into valuations that support exits, though capital markets solutions, liability management, and continuation vehicles are providing alternatives. On AI, management said the firm is still in early deployment, sees potential productivity gains, but is also focused on data protection and believes some benefits will be commoditized across the industry.
The bullish case from the call is that Moelis is gaining share in larger M&A transactions while also building out non-M&A businesses that are already producing record revenue. Management said the announced pipeline is up more than 80% year over year, new business origination accelerated, and the firm has more depth in capital markets, PCA, and CSA than before.
The main risks discussed were sponsor M&A still not fully recovering, especially in the middle market, and higher leverage and AI disruption creating tougher exits for some portfolio companies. Management also noted competitive pressure for senior banker talent, ongoing expense growth from business activity and underwriting costs, and uncertainty around how quickly AI will translate into durable operating leverage.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.0%
- Shares Outstanding
- 74.08M
- Float Shares
- 73.33M
of shares held by institutions
405 13F filers
Buy/sell ratio 6.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for MC, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Donna ShalalaHouse · FL27 | Sell | Jan 9, 19 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 9.06M | ▲ 255.84K |
| Vanguard Group Inc | 8.51M | ▼ 223.42K |
| Kayne Anderson Rudnick Investment Management LLC | 5.41M | ▼ 364.83K |
| Vanguard Capital Management LLC | 3.35M | ▲ 36.32K |
| Wasatch Advisors LP | 3.25M | ▼ 496.03K |
| State Street Corp | 3.04M | ▲ 123.73K |
| Sixth Street Partners Management Company, L.P. | 2.96M | ▲ 2.96M |
| Charles Schwab Investment Management Inc | 2.96M | ▲ 252.05K |
| London Co Of Virginia | 2.79M | ▼ 112.75K |
| Geode Capital Management, LLC | 2.36M | ▲ 190.22K |
| Ameriprise Financial Inc | 2.34M | ▲ 197.64K |
| Hightower Advisors, LLC | 1.84M | ▲ 58.12K |
Held by 419 ETFs
Biggest fund positions in MC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 4, 26 | WATANABE OSAMU R. | sell | 4,850 |
| Jul 1, 26 | Barker Thorold | other | 1,545 |
| Jul 1, 26 | Mirrer Louise | other | 1,623 |
| Jul 1, 26 | Worrell Laila | other | 1,777 |
| Jul 1, 26 | Worrell Laila | other | 1,623 |
| Jul 1, 26 | Shropshire Kenneth | other | 1,700 |
| Jul 1, 26 | Shropshire Kenneth | other | 200 |
| Jun 18, 26 | Barker Thorold | other | 15.96 |
| Jun 18, 26 | Mirrer Louise | other | 16.76 |
| Jun 18, 26 | Mirrer Louise | other | 12.39 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MC coverage
Recent articles, reports, and earnings notes.
Want a deeper read on MC?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Moelis & Company (NYSE:MC) Stock Crosses Above 50-Day Moving Average – Should You Sell?
defenseworld.net · Aug 20
Arrowstreet Capital Limited Partnership Makes New $15.62 Million Investment in Moelis & Company $MC
defenseworld.net · Jul 31
Moelis & Company Q2 Earnings Beat Estimates on Higher Revenues
zacks.com · Jul 30
Moelis & Company Q2 Earnings Call Highlights
marketbeat.com · Jul 30
Moelis & Company (MC) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 29
Moelis (MC) Q2 Earnings and Revenues Beat Estimates
zacks.com · Jul 29
Moelis & Company Reports Second Quarter and First Half 2026 Financial Results; Declares Regular Quarterly Dividend of $0.65 Per Share
businesswire.com · Jul 29
Why Moelis (MC) is a Top Momentum Stock for the Long-Term
zacks.com · Jul 28
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed August 15, 2026 · Live quote · Not investment advice
